SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001072613-14-000151
Filing Date
2014-02-26
Accepted
2014-02-26 11:22:26
Documents
1
Group Members
CLARUS VENTURES II GP L.P.CLARUS VENTURES II LLCDENNIS HENNERKURT WHEELERMICHAEL STEINMETZNICHOLAS GALAKATOSNICHOLAS SIMONROBERT LIPTAK

Document Format Files

Seq Description Document Type Size
1 OPHTHOTECH CORPORATION clarus-ophthosch13d_17623.htm SC 13D/A 271654
  Complete submission text file 0001072613-14-000151.txt   273429
Mailing Address ONE PENN PLAZA 35TH FLOOR NEW YORK NY 10119
Business Address ONE PENN PLAZA 35TH FLOOR NEW YORK NY 10119 212-845-8200
Ophthotech Corp. (Subject) CIK: 0001410939 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87636 | Film No.: 14643303
SIC: 2834 Pharmaceutical Preparations

Mailing Address 101 MAIN STREET SUITE 1210 CAMBRIDGE MA 02142
Business Address 101 MAIN STREET SUITE 1210 CAMBRIDGE MA 02142 617-949-2200
Clarus Lifesciences II, L.P. (Filed by) CIK: 0001431443 (see all company filings)

IRS No.: 261856183 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A